Supplementary Table S2 from The SOS1 Inhibitor BI 1701963 as Monotherapy or in Combination with Trametinib in Patients with <i>KRAS</i> Mutation-Positive Solid Tumors

作者：Pasi A. Jänne, Melissa L. Johnson, Jin Li, Shubham Pant, Ulrich Dünzinger, Luis Ilia, Kerstin Möldner, Jae Eui Soh, Noboru Yamamoto · 年份：2026 · DOI：10.1158/1078-0432.33143543 · 研究领域：Medicine、Cancer research、Pharmacology、Internal medicine、Chemistry、Oncology

<p>Supplementary Table S2: Representativeness of study participants with KRAS mutation-positive solid tumors</p>